Tokushima, Japan

Yoshimasa Yonemoto

This inventor holds 1 USPTO granted patent. Top assignees: Gunze Limited, Otsuka Kagaku Kabushiki Kaisha, Other. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshimasa Yonemoto. Retrieved from https://idiyas.com/inventor/yoshimasa-yonemoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Yoshimasa Yonemoto

Introduction

Yoshimasa Yonemoto is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of therapeutic medicine, particularly in the treatment of cystic fibrosis. His innovative work has led to the development of a patent that addresses this challenging medical condition.

Latest Patents

Yoshimasa Yonemoto holds a patent for a therapeutic medicine specifically designed for cystic fibrosis. This patent represents a crucial advancement in medical treatment options for patients suffering from this genetic disorder. He has 1 patent to his name, showcasing his commitment to innovation in healthcare.

Career Highlights

Throughout his career, Yonemoto has worked with various companies, including Gunze Limited. His experience in the industry has allowed him to develop and refine his ideas, leading to impactful inventions that benefit society.

Collaborations

Yoshimasa Yonemoto has collaborated with notable individuals in his field, including Kenji Sakaguchi and Shiro Abe. These partnerships have fostered a creative environment that encourages the exchange of ideas and expertise.

Conclusion

Yoshimasa Yonemoto's contributions to therapeutic medicine highlight the importance of innovation in addressing complex health issues. His work continues to inspire future advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…